SSA
SRNE

Schonfeld Strategic Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-378,068
Closed -$593K – 3115
2022
Q3 		$593K Buy
+378,068
New +$593K 0.01% 1607